[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f-WAIZ_XVBikyz1XDR2Tscoeamwdc0RrYx88ocldUWbA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":49,"rows":56},"TriHealth Inc.",[4],102,false,10,6,40535,5,72,[14,17,19,22,24,26,29,31],{"name":15,"count":16},"Pelvic Organ Prolapse",14,{"name":18,"count":11},"Pain, Postoperative",{"name":20,"count":21},"Postoperative Pain",3,{"name":23,"count":21},"Arthroplasty, Replacement, Knee",{"name":25,"count":21},"Overactive Bladder",{"name":27,"count":28},"Cesarean Section",2,{"name":30,"count":28},"Hepatitis C",{"name":32,"count":28},"Obstetric Trauma",[34,39,44],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06843538","Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery","2026-02-01","Tamsulosin",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07260825","Use of Topical Testosterone and Estrogen vs Estrogen Alone in Vulvodynia: a Randomized Controlled Trial","2026-07","Estradiol 0.01% Vag Cream",{"nctId":45,"briefTitle":46,"date":47,"intervention":48},"NCT07387315","A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections","2026-11","Pro-Nox Nitrous Oxide\u002FOxygen Delivery System",[50,51,52,53,54,55],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[57,91,109,134,152,175,223,259,284,311,329,354,372,394,412,430,448,475,502,530,556,574,600,625,651,677,707,725,743,772,796,820,845,870,888,913,931,956,981,999,1024],{"intervention":48,"totalTrials":58,"cells":59},1,{"EARLY_PHASE1":60,"PHASE1":63,"PHASE2":65,"PHASE3":67,"PHASE4":69,"NA":89},{"trials":61,"activeCount":62},[],0,{"trials":64,"activeCount":62},[],{"trials":66,"activeCount":62},[],{"trials":68,"activeCount":62},[],{"trials":70,"activeCount":58,"soonestReadout":47},[71],{"nctId":45,"briefTitle":46,"status":72,"phases":73,"primaryCompletion":47,"completion":74,"start":75,"enrollment":76,"conditions":77,"interventions":87},"NOT_YET_RECRUITING",[54],"2026-12","2026-02",96,[25,78,79,80,81,82,83,84,85,86],"Neurogenic Bladder","Urge Incontinence","Pain","Urinary Incontinence","Urinary Bladder, Overactive","Urinary Bladder, Neurogenic","Urinary Bladder Neurogenesis","Urinary Incontinence, Urge","Pelvic Floor Disorders",[48,88],"Standard Care for Bladder Botox",{"trials":90,"activeCount":62},[],{"intervention":88,"totalTrials":58,"cells":92},{"EARLY_PHASE1":93,"PHASE1":95,"PHASE2":97,"PHASE3":99,"PHASE4":101,"NA":107},{"trials":94,"activeCount":62},[],{"trials":96,"activeCount":62},[],{"trials":98,"activeCount":62},[],{"trials":100,"activeCount":62},[],{"trials":102,"activeCount":58,"soonestReadout":47},[103],{"nctId":45,"briefTitle":46,"status":72,"phases":104,"primaryCompletion":47,"completion":74,"start":75,"enrollment":76,"conditions":105,"interventions":106},[54],[25,78,79,80,81,82,83,84,85,86],[48,88],{"trials":108,"activeCount":62},[],{"intervention":43,"totalTrials":58,"cells":110},{"EARLY_PHASE1":111,"PHASE1":113,"PHASE2":115,"PHASE3":117,"PHASE4":130,"NA":132},{"trials":112,"activeCount":62},[],{"trials":114,"activeCount":62},[],{"trials":116,"activeCount":62},[],{"trials":118,"activeCount":58,"soonestReadout":42},[119],{"nctId":40,"briefTitle":41,"status":72,"phases":120,"primaryCompletion":42,"completion":121,"start":122,"enrollment":123,"conditions":124,"interventions":128},[52,53],"2026-08","2025-12",44,[125,126,127],"Vulvodynia","Dyspareunia","Lichen Sclerosus of Vulva",[43,129],"testosterone 0.1% and estradiol 0.01% vaginal cream",{"trials":131,"activeCount":62},[],{"trials":133,"activeCount":62},[],{"intervention":129,"totalTrials":58,"cells":135},{"EARLY_PHASE1":136,"PHASE1":138,"PHASE2":140,"PHASE3":142,"PHASE4":148,"NA":150},{"trials":137,"activeCount":62},[],{"trials":139,"activeCount":62},[],{"trials":141,"activeCount":62},[],{"trials":143,"activeCount":58,"soonestReadout":42},[144],{"nctId":40,"briefTitle":41,"status":72,"phases":145,"primaryCompletion":42,"completion":121,"start":122,"enrollment":123,"conditions":146,"interventions":147},[52,53],[125,126,127],[43,129],{"trials":149,"activeCount":62},[],{"trials":151,"activeCount":62},[],{"intervention":38,"totalTrials":58,"cells":153},{"EARLY_PHASE1":154,"PHASE1":156,"PHASE2":158,"PHASE3":160,"PHASE4":171,"NA":173},{"trials":155,"activeCount":62},[],{"trials":157,"activeCount":62},[],{"trials":159,"activeCount":62},[],{"trials":161,"activeCount":58,"soonestReadout":37},[162],{"nctId":35,"briefTitle":36,"status":163,"phases":164,"primaryCompletion":37,"completion":165,"start":166,"enrollment":167,"conditions":168,"interventions":170},"RECRUITING",[53],"2026-06-01","2025-02-03",166,[169],"Postoperative Urinary Retention (POUR)",[38],{"trials":172,"activeCount":62},[],{"trials":174,"activeCount":62},[],{"intervention":176,"totalTrials":21,"cells":177},"IV Acetaminophen",{"EARLY_PHASE1":178,"PHASE1":180,"PHASE2":182,"PHASE3":184,"PHASE4":186,"NA":221},{"trials":179,"activeCount":62},[],{"trials":181,"activeCount":62},[],{"trials":183,"activeCount":62},[],{"trials":185,"activeCount":62},[],{"trials":187,"activeCount":62},[188,199,208],{"nctId":189,"briefTitle":190,"status":191,"phases":192,"primaryCompletion":193,"completion":194,"start":195,"enrollment":196,"conditions":197,"interventions":198},"NCT02046382","RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief","COMPLETED",[54],"2016-12","2017-05","2014-01",132,[27,18],[176],{"nctId":200,"briefTitle":201,"status":191,"phases":202,"primaryCompletion":203,"completion":203,"start":195,"enrollment":204,"conditions":205,"interventions":207},"NCT02043704","RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain",[54],"2016-08",100,[206],"Post Operative Pain",[176],{"nctId":209,"briefTitle":210,"status":191,"phases":211,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":216,"interventions":217},"NCT03468920","Preoperative IV Versus Oral Acetaminophen",[54],"2019-02-14","2019-04-12","2018-04-01",120,[18],[176,218,219,220],"PO Acetaminophen","PO Placebo","IV Solution Placebo",{"trials":222,"activeCount":62},[],{"intervention":224,"totalTrials":28,"cells":225},"Liposomal bupivacaine",{"EARLY_PHASE1":226,"PHASE1":228,"PHASE2":230,"PHASE3":232,"PHASE4":234,"NA":257},{"trials":227,"activeCount":62},[],{"trials":229,"activeCount":62},[],{"trials":231,"activeCount":62},[],{"trials":233,"activeCount":62},[],{"trials":235,"activeCount":62},[236,247],{"nctId":237,"briefTitle":238,"status":239,"phases":240,"primaryCompletion":241,"completion":242,"start":243,"enrollment":244,"conditions":245,"interventions":246},"NCT02591888","Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling","TERMINATED",[54],"2017-03","2017-12","2015-02",18,[80],[224],{"nctId":248,"briefTitle":249,"status":191,"phases":250,"primaryCompletion":203,"completion":203,"start":251,"enrollment":252,"conditions":253,"interventions":255},"NCT02296099","Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence",[54],"2014-11",114,[254],"Urinary Incontinence, Stress",[256],"liposomal bupivacaine",{"trials":258,"activeCount":62},[],{"intervention":260,"totalTrials":58,"cells":261},"local infiltration of liposomal bupivacaine",{"EARLY_PHASE1":262,"PHASE1":264,"PHASE2":266,"PHASE3":268,"PHASE4":270,"NA":282},{"trials":263,"activeCount":62},[],{"trials":265,"activeCount":62},[],{"trials":267,"activeCount":62},[],{"trials":269,"activeCount":62},[],{"trials":271,"activeCount":62},[272],{"nctId":273,"briefTitle":274,"status":275,"phases":276,"primaryCompletion":277,"completion":277,"start":278,"enrollment":62,"conditions":279,"interventions":281},"NCT03474510","Effective Pain Management During Shoulder Replacement Surgery With EXPAREL","WITHDRAWN",[54],"2019-02-01","2018-03-17",[18,280],"Shoulder Osteoarthritis",[260],{"trials":283,"activeCount":62},[],{"intervention":285,"totalTrials":58,"cells":286},"Chlorhexidine",{"EARLY_PHASE1":287,"PHASE1":289,"PHASE2":291,"PHASE3":293,"PHASE4":295,"NA":309},{"trials":288,"activeCount":62},[],{"trials":290,"activeCount":62},[],{"trials":292,"activeCount":62},[],{"trials":294,"activeCount":62},[],{"trials":296,"activeCount":62},[297],{"nctId":298,"briefTitle":299,"status":239,"phases":300,"primaryCompletion":301,"completion":302,"start":303,"enrollment":304,"conditions":305,"interventions":307},"NCT03412734","Vaginal Preparation Prior to Hysterectomy",[54],"2019-08-26","2020-01-29","2018-05-18",94,[306],"Hysterectomy",[285,308],"Iodine",{"trials":310,"activeCount":62},[],{"intervention":308,"totalTrials":58,"cells":312},{"EARLY_PHASE1":313,"PHASE1":315,"PHASE2":317,"PHASE3":319,"PHASE4":321,"NA":327},{"trials":314,"activeCount":62},[],{"trials":316,"activeCount":62},[],{"trials":318,"activeCount":62},[],{"trials":320,"activeCount":62},[],{"trials":322,"activeCount":62},[323],{"nctId":298,"briefTitle":299,"status":239,"phases":324,"primaryCompletion":301,"completion":302,"start":303,"enrollment":304,"conditions":325,"interventions":326},[54],[306],[285,308],{"trials":328,"activeCount":62},[],{"intervention":330,"totalTrials":58,"cells":331},"Lidocaine Ropivacaine",{"EARLY_PHASE1":332,"PHASE1":334,"PHASE2":336,"PHASE3":338,"PHASE4":340,"NA":352},{"trials":333,"activeCount":62},[],{"trials":335,"activeCount":62},[],{"trials":337,"activeCount":62},[],{"trials":339,"activeCount":62},[],{"trials":341,"activeCount":62},[342],{"nctId":343,"briefTitle":344,"status":275,"phases":345,"primaryCompletion":346,"completion":346,"start":347,"enrollment":62,"conditions":348,"interventions":350},"NCT02085239","Comparison of Long vs. Short Acting Anesthesia for Improving Pain Management After Breast Biopsy",[54],"2015-03","2013-08",[349],"Pain Management After Breast Biopsy",[330,351],"Lidocaine alone",{"trials":353,"activeCount":62},[],{"intervention":351,"totalTrials":58,"cells":355},{"EARLY_PHASE1":356,"PHASE1":358,"PHASE2":360,"PHASE3":362,"PHASE4":364,"NA":370},{"trials":357,"activeCount":62},[],{"trials":359,"activeCount":62},[],{"trials":361,"activeCount":62},[],{"trials":363,"activeCount":62},[],{"trials":365,"activeCount":62},[366],{"nctId":343,"briefTitle":344,"status":275,"phases":367,"primaryCompletion":346,"completion":346,"start":347,"enrollment":62,"conditions":368,"interventions":369},[54],[349],[330,351],{"trials":371,"activeCount":62},[],{"intervention":373,"totalTrials":58,"cells":374},"Bupivacaine",{"EARLY_PHASE1":375,"PHASE1":377,"PHASE2":379,"PHASE3":381,"PHASE4":383,"NA":392},{"trials":376,"activeCount":62},[],{"trials":378,"activeCount":62},[],{"trials":380,"activeCount":62},[],{"trials":382,"activeCount":62},[],{"trials":384,"activeCount":62},[385],{"nctId":386,"briefTitle":387,"status":191,"phases":388,"primaryCompletion":203,"completion":203,"start":346,"enrollment":389,"conditions":390,"interventions":391},"NCT02449915","Improvement of Pain Following Robotic Sacrocolpopexy and Rectocele Repair for Pelvic Organ Prolapse",[54],70,[15],[373],{"trials":393,"activeCount":62},[],{"intervention":218,"totalTrials":58,"cells":395},{"EARLY_PHASE1":396,"PHASE1":398,"PHASE2":400,"PHASE3":402,"PHASE4":404,"NA":410},{"trials":397,"activeCount":62},[],{"trials":399,"activeCount":62},[],{"trials":401,"activeCount":62},[],{"trials":403,"activeCount":62},[],{"trials":405,"activeCount":62},[406],{"nctId":209,"briefTitle":210,"status":191,"phases":407,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":408,"interventions":409},[54],[18],[176,218,219,220],{"trials":411,"activeCount":62},[],{"intervention":219,"totalTrials":58,"cells":413},{"EARLY_PHASE1":414,"PHASE1":416,"PHASE2":418,"PHASE3":420,"PHASE4":422,"NA":428},{"trials":415,"activeCount":62},[],{"trials":417,"activeCount":62},[],{"trials":419,"activeCount":62},[],{"trials":421,"activeCount":62},[],{"trials":423,"activeCount":62},[424],{"nctId":209,"briefTitle":210,"status":191,"phases":425,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":426,"interventions":427},[54],[18],[176,218,219,220],{"trials":429,"activeCount":62},[],{"intervention":220,"totalTrials":58,"cells":431},{"EARLY_PHASE1":432,"PHASE1":434,"PHASE2":436,"PHASE3":438,"PHASE4":440,"NA":446},{"trials":433,"activeCount":62},[],{"trials":435,"activeCount":62},[],{"trials":437,"activeCount":62},[],{"trials":439,"activeCount":62},[],{"trials":441,"activeCount":62},[442],{"nctId":209,"briefTitle":210,"status":191,"phases":443,"primaryCompletion":212,"completion":213,"start":214,"enrollment":215,"conditions":444,"interventions":445},[54],[18],[176,218,219,220],{"trials":447,"activeCount":62},[],{"intervention":449,"totalTrials":58,"cells":450},"Saline-only catheter flush",{"EARLY_PHASE1":451,"PHASE1":453,"PHASE2":455,"PHASE3":457,"PHASE4":459,"NA":473},{"trials":452,"activeCount":62},[],{"trials":454,"activeCount":62},[],{"trials":456,"activeCount":62},[],{"trials":458,"activeCount":62},[],{"trials":460,"activeCount":62},[461],{"nctId":462,"briefTitle":463,"status":239,"phases":464,"primaryCompletion":465,"completion":466,"start":467,"enrollment":468,"conditions":469,"interventions":472},"NCT02923830","Maintaining Patency in BioFlo Implanted Port Catheters With Saline Only Flushes",[54],"2017-11","2019-03-26","2016-04",28,[470,471],"Obstruction; Catheter, Infusion Catheter (Vascular)","Catheter; Complications (Indwelling Catheter)",[449],{"trials":474,"activeCount":62},[],{"intervention":476,"totalTrials":58,"cells":477},"Placebos",{"EARLY_PHASE1":478,"PHASE1":480,"PHASE2":482,"PHASE3":484,"PHASE4":486,"NA":500},{"trials":479,"activeCount":62},[],{"trials":481,"activeCount":62},[],{"trials":483,"activeCount":62},[],{"trials":485,"activeCount":62},[],{"trials":487,"activeCount":62},[488],{"nctId":489,"briefTitle":490,"status":491,"phases":492,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":497,"interventions":498},"NCT04198233","Impact of Placement of a Diazepam Suppository on Early Postoperative Pain Following Pelvic Reconstructive Surgery","UNKNOWN",[54],"2022-05","2022-12","2020-02-12",130,[20],[499,476],"Diazepam",{"trials":501,"activeCount":62},[],{"intervention":503,"totalTrials":58,"cells":504},"Bupivacaine-Meloxicam",{"EARLY_PHASE1":505,"PHASE1":507,"PHASE2":509,"PHASE3":511,"PHASE4":526,"NA":528},{"trials":506,"activeCount":62},[],{"trials":508,"activeCount":62},[],{"trials":510,"activeCount":62},[],{"trials":512,"activeCount":62},[513],{"nctId":514,"briefTitle":515,"status":191,"phases":516,"primaryCompletion":517,"completion":518,"start":519,"enrollment":520,"conditions":521,"interventions":525},"NCT05702827","Use of a Dual-agent Local Analgesic (Bupivacaine-meloxicam) for Abdominal Incisions in Patients Undergoing Retropubic Mid-urethral Sling Surgery",[53],"2024-03-22","2024-04-18","2023-01-23",148,[522,523,524],"Stress Urinary Incontinence","Surgical Incision","Pain Vulva",[503],{"trials":527,"activeCount":62},[],{"trials":529,"activeCount":62},[],{"intervention":531,"totalTrials":58,"cells":532},"Vaginal conjugated estrogen cream 0.5gm",{"EARLY_PHASE1":533,"PHASE1":535,"PHASE2":537,"PHASE3":539,"PHASE4":552,"NA":554},{"trials":534,"activeCount":62},[],{"trials":536,"activeCount":62},[],{"trials":538,"activeCount":62},[],{"trials":540,"activeCount":62},[541],{"nctId":542,"briefTitle":543,"status":191,"phases":544,"primaryCompletion":545,"completion":545,"start":546,"enrollment":547,"conditions":548,"interventions":550},"NCT00803335","The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse",[53],"2011-05","2008-12",54,[15,549],"Vaginal Atrophy",[531,551],"Vaginal conjugated estrogen cream 1.0gm",{"trials":553,"activeCount":62},[],{"trials":555,"activeCount":62},[],{"intervention":551,"totalTrials":58,"cells":557},{"EARLY_PHASE1":558,"PHASE1":560,"PHASE2":562,"PHASE3":564,"PHASE4":570,"NA":572},{"trials":559,"activeCount":62},[],{"trials":561,"activeCount":62},[],{"trials":563,"activeCount":62},[],{"trials":565,"activeCount":62},[566],{"nctId":542,"briefTitle":543,"status":191,"phases":567,"primaryCompletion":545,"completion":545,"start":546,"enrollment":547,"conditions":568,"interventions":569},[53],[15,549],[531,551],{"trials":571,"activeCount":62},[],{"trials":573,"activeCount":62},[],{"intervention":575,"totalTrials":58,"cells":576},"Naloxegol 25 MG",{"EARLY_PHASE1":577,"PHASE1":579,"PHASE2":581,"PHASE3":583,"PHASE4":596,"NA":598},{"trials":578,"activeCount":62},[],{"trials":580,"activeCount":62},[],{"trials":582,"activeCount":62},[],{"trials":584,"activeCount":62},[585],{"nctId":586,"briefTitle":587,"status":491,"phases":588,"primaryCompletion":589,"completion":589,"start":590,"enrollment":591,"conditions":592,"interventions":595},"NCT03316859","Naloxegol and Opioid-induced Constipation",[52,53],"2022-12-01","2017-11-06",280,[593,594],"Constipation","Constipation Drug Induced",[575],{"trials":597,"activeCount":62},[],{"trials":599,"activeCount":62},[],{"intervention":601,"totalTrials":58,"cells":602},"Dexamethasone",{"EARLY_PHASE1":603,"PHASE1":605,"PHASE2":607,"PHASE3":609,"PHASE4":621,"NA":623},{"trials":604,"activeCount":62},[],{"trials":606,"activeCount":62},[],{"trials":608,"activeCount":62},[],{"trials":610,"activeCount":62},[611],{"nctId":612,"briefTitle":613,"status":191,"phases":614,"primaryCompletion":615,"completion":615,"start":616,"enrollment":617,"conditions":618,"interventions":620},"NCT02073734","Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP",[53],"2014-08","2013-02",63,[15,619],"PONV",[601],{"trials":622,"activeCount":62},[],{"trials":624,"activeCount":62},[],{"intervention":626,"totalTrials":58,"cells":627},"Convalescent Plasma",{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":645,"PHASE4":647,"NA":649},{"trials":629,"activeCount":62},[],{"trials":631,"activeCount":62},[],{"trials":633,"activeCount":62},[634],{"nctId":635,"briefTitle":636,"status":191,"phases":637,"primaryCompletion":638,"completion":638,"start":639,"enrollment":640,"conditions":641,"interventions":644},"NCT04392232","A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection",[52],"2021-09-21","2020-05-05",159,[642,643,626],"Coronavirus","COVID-19",[626],{"trials":646,"activeCount":62},[],{"trials":648,"activeCount":62},[],{"trials":650,"activeCount":62},[],{"intervention":652,"totalTrials":58,"cells":653},"Methenamine Hippurate 1 g",{"EARLY_PHASE1":654,"PHASE1":656,"PHASE2":658,"PHASE3":671,"PHASE4":673,"NA":675},{"trials":655,"activeCount":62},[],{"trials":657,"activeCount":62},[],{"trials":659,"activeCount":62},[660],{"nctId":661,"briefTitle":662,"status":191,"phases":663,"primaryCompletion":664,"completion":664,"start":665,"enrollment":666,"conditions":667,"interventions":670},"NCT03818321","Urinary Track Infection Prevention After Urogynecological Surgery",[52],"2021-07-01","2019-06-17",185,[668,669,15],"Urinary Tract Infections","Urinary Retention Postoperative",[652],{"trials":672,"activeCount":62},[],{"trials":674,"activeCount":62},[],{"trials":676,"activeCount":62},[],{"intervention":678,"totalTrials":58,"cells":679},"Talimogene laherparepvec",{"EARLY_PHASE1":680,"PHASE1":682,"PHASE2":684,"PHASE3":701,"PHASE4":703,"NA":705},{"trials":681,"activeCount":62},[],{"trials":683,"activeCount":62},[],{"trials":685,"activeCount":62},[686],{"nctId":687,"briefTitle":688,"status":275,"phases":689,"primaryCompletion":690,"completion":690,"start":691,"enrollment":62,"conditions":692,"interventions":698},"NCT03972046","Neoadjuvant Use of Talimogene Laherparepvec and BRAF\u002FMEK Inhibitor for Advanced Nodal BRAF Mutant Melanoma",[52],"2020-02-03","2019-06-24",[693,694,695,696,697],"Melanoma (Skin)","Melanoma Stage IIIb-IVM1a","Metastasis Skin","Tumor Skin","BRAF Gene Mutation",[678,699,700],"Dabrafenib","Trametinib",{"trials":702,"activeCount":62},[],{"trials":704,"activeCount":62},[],{"trials":706,"activeCount":62},[],{"intervention":699,"totalTrials":58,"cells":708},{"EARLY_PHASE1":709,"PHASE1":711,"PHASE2":713,"PHASE3":719,"PHASE4":721,"NA":723},{"trials":710,"activeCount":62},[],{"trials":712,"activeCount":62},[],{"trials":714,"activeCount":62},[715],{"nctId":687,"briefTitle":688,"status":275,"phases":716,"primaryCompletion":690,"completion":690,"start":691,"enrollment":62,"conditions":717,"interventions":718},[52],[693,694,695,696,697],[678,699,700],{"trials":720,"activeCount":62},[],{"trials":722,"activeCount":62},[],{"trials":724,"activeCount":62},[],{"intervention":700,"totalTrials":58,"cells":726},{"EARLY_PHASE1":727,"PHASE1":729,"PHASE2":731,"PHASE3":737,"PHASE4":739,"NA":741},{"trials":728,"activeCount":62},[],{"trials":730,"activeCount":62},[],{"trials":732,"activeCount":62},[733],{"nctId":687,"briefTitle":688,"status":275,"phases":734,"primaryCompletion":690,"completion":690,"start":691,"enrollment":62,"conditions":735,"interventions":736},[52],[693,694,695,696,697],[678,699,700],{"trials":738,"activeCount":62},[],{"trials":740,"activeCount":62},[],{"trials":742,"activeCount":62},[],{"intervention":499,"totalTrials":28,"cells":744},{"EARLY_PHASE1":745,"PHASE1":747,"PHASE2":749,"PHASE3":751,"PHASE4":753,"NA":759},{"trials":746,"activeCount":62},[],{"trials":748,"activeCount":62},[],{"trials":750,"activeCount":62},[],{"trials":752,"activeCount":62},[],{"trials":754,"activeCount":62},[755],{"nctId":489,"briefTitle":490,"status":491,"phases":756,"primaryCompletion":493,"completion":494,"start":495,"enrollment":496,"conditions":757,"interventions":758},[54],[20],[499,476],{"trials":760,"activeCount":62},[761],{"nctId":762,"briefTitle":763,"status":191,"phases":764,"primaryCompletion":765,"completion":765,"start":766,"enrollment":767,"conditions":768,"interventions":770},"NCT02799641","Effect of Multimodal Analgesia on Pain With Insertion of Levonorgestrel-releasing IUD",[55],"2022-06","2016-07",61,[769],"Contraception",[499,771],"Lidocaine",{"intervention":773,"totalTrials":58,"cells":774},"Genetic Panel for Analgesics",{"EARLY_PHASE1":775,"PHASE1":777,"PHASE2":779,"PHASE3":781,"PHASE4":783,"NA":785},{"trials":776,"activeCount":62},[],{"trials":778,"activeCount":62},[],{"trials":780,"activeCount":62},[],{"trials":782,"activeCount":62},[],{"trials":784,"activeCount":62},[],{"trials":786,"activeCount":62},[787],{"nctId":788,"briefTitle":789,"status":239,"phases":790,"primaryCompletion":791,"completion":791,"start":792,"enrollment":793,"conditions":794,"interventions":795},"NCT02711592","Pharmacogenomics Information in Enhancing Post-operative Total Joint Replacement Pain Management: a Pilot Study",[55],"2019-08-22","2016-10-05",4,[23,18],[773],{"intervention":797,"totalTrials":58,"cells":798},"Omega 3 Fatty Acid",{"EARLY_PHASE1":799,"PHASE1":801,"PHASE2":803,"PHASE3":805,"PHASE4":807,"NA":809},{"trials":800,"activeCount":62},[],{"trials":802,"activeCount":62},[],{"trials":804,"activeCount":62},[],{"trials":806,"activeCount":62},[],{"trials":808,"activeCount":62},[],{"trials":810,"activeCount":62},[811],{"nctId":812,"briefTitle":813,"status":239,"phases":814,"primaryCompletion":815,"completion":815,"start":816,"enrollment":817,"conditions":818,"interventions":819},"NCT02070042","Oxybutynin and Omega-3 for OAB (Overactive Bladder)",[55],"2015-09","2014-02",31,[25],[797],{"intervention":821,"totalTrials":58,"cells":822},"Vaginal and rectovaginal swab cultures",{"EARLY_PHASE1":823,"PHASE1":825,"PHASE2":827,"PHASE3":829,"PHASE4":831,"NA":833},{"trials":824,"activeCount":62},[],{"trials":826,"activeCount":62},[],{"trials":828,"activeCount":62},[],{"trials":830,"activeCount":62},[],{"trials":832,"activeCount":62},[],{"trials":834,"activeCount":62},[835],{"nctId":836,"briefTitle":837,"status":239,"phases":838,"primaryCompletion":839,"completion":839,"start":840,"enrollment":841,"conditions":842,"interventions":844},"NCT02814318","Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization",[],"2019-10","2016-06",41,[843],"Group B Streptococcal Infection",[821],{"intervention":846,"totalTrials":58,"cells":847},"Senna",{"EARLY_PHASE1":848,"PHASE1":850,"PHASE2":852,"PHASE3":854,"PHASE4":856,"NA":858},{"trials":849,"activeCount":62},[],{"trials":851,"activeCount":62},[],{"trials":853,"activeCount":62},[],{"trials":855,"activeCount":62},[],{"trials":857,"activeCount":62},[],{"trials":859,"activeCount":62},[860],{"nctId":861,"briefTitle":862,"status":239,"phases":863,"primaryCompletion":840,"completion":840,"start":864,"enrollment":865,"conditions":866,"interventions":868},"NCT02239510","Efficacy of Linaclotide to Senna for CIC",[55],"2014-09",9,[867],"Chronic Idiopathic Constipation",[846,869],"Linzess",{"intervention":869,"totalTrials":58,"cells":871},{"EARLY_PHASE1":872,"PHASE1":874,"PHASE2":876,"PHASE3":878,"PHASE4":880,"NA":882},{"trials":873,"activeCount":62},[],{"trials":875,"activeCount":62},[],{"trials":877,"activeCount":62},[],{"trials":879,"activeCount":62},[],{"trials":881,"activeCount":62},[],{"trials":883,"activeCount":62},[884],{"nctId":861,"briefTitle":862,"status":239,"phases":885,"primaryCompletion":840,"completion":840,"start":864,"enrollment":865,"conditions":886,"interventions":887},[55],[867],[846,869],{"intervention":889,"totalTrials":58,"cells":890},"bupivacaine liposome suspension",{"EARLY_PHASE1":891,"PHASE1":893,"PHASE2":895,"PHASE3":897,"PHASE4":899,"NA":901},{"trials":892,"activeCount":62},[],{"trials":894,"activeCount":62},[],{"trials":896,"activeCount":62},[],{"trials":898,"activeCount":62},[],{"trials":900,"activeCount":62},[],{"trials":902,"activeCount":62},[903],{"nctId":904,"briefTitle":905,"status":191,"phases":906,"primaryCompletion":907,"completion":908,"start":347,"enrollment":389,"conditions":909,"interventions":911},"NCT02299349","Bupivacaine Liposome Suspension Versus a Concentrated Multi Drug Periarticular Injection",[55],"2013-12","2014-03",[910],"Total Knee Arthroplasty",[889,912],"concentrated multi drug Ketorlac, Morphine PF, Epinephrine, Ropivicaine, 0.9% NaCL",{"intervention":912,"totalTrials":58,"cells":914},{"EARLY_PHASE1":915,"PHASE1":917,"PHASE2":919,"PHASE3":921,"PHASE4":923,"NA":925},{"trials":916,"activeCount":62},[],{"trials":918,"activeCount":62},[],{"trials":920,"activeCount":62},[],{"trials":922,"activeCount":62},[],{"trials":924,"activeCount":62},[],{"trials":926,"activeCount":62},[927],{"nctId":904,"briefTitle":905,"status":191,"phases":928,"primaryCompletion":907,"completion":908,"start":347,"enrollment":389,"conditions":929,"interventions":930},[55],[910],[889,912],{"intervention":932,"totalTrials":58,"cells":933},"Ropivacaine",{"EARLY_PHASE1":934,"PHASE1":936,"PHASE2":938,"PHASE3":940,"PHASE4":942,"NA":944},{"trials":935,"activeCount":62},[],{"trials":937,"activeCount":62},[],{"trials":939,"activeCount":62},[],{"trials":941,"activeCount":62},[],{"trials":943,"activeCount":62},[],{"trials":945,"activeCount":62},[946],{"nctId":947,"briefTitle":948,"status":191,"phases":949,"primaryCompletion":950,"completion":951,"start":615,"enrollment":952,"conditions":953,"interventions":955},"NCT02267044","Effective Pain Management of Interscalene Blocks During Shoulder Surgery",[55],"2016-10","2017-04",76,[954],"Primary Osteoarthritis, Unspecified Shoulder",[932],{"intervention":957,"totalTrials":58,"cells":958},"Dilaudid PCA",{"EARLY_PHASE1":959,"PHASE1":961,"PHASE2":963,"PHASE3":965,"PHASE4":967,"NA":969},{"trials":960,"activeCount":62},[],{"trials":962,"activeCount":62},[],{"trials":964,"activeCount":62},[],{"trials":966,"activeCount":62},[],{"trials":968,"activeCount":62},[],{"trials":970,"activeCount":62},[971],{"nctId":972,"briefTitle":973,"status":191,"phases":974,"primaryCompletion":975,"completion":976,"start":977,"enrollment":547,"conditions":978,"interventions":979},"NCT01442818","Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery",[55],"2011-09","2012-10","2010-09",[206],[957,980],"Dilaudid IV Scheduled",{"intervention":980,"totalTrials":58,"cells":982},{"EARLY_PHASE1":983,"PHASE1":985,"PHASE2":987,"PHASE3":989,"PHASE4":991,"NA":993},{"trials":984,"activeCount":62},[],{"trials":986,"activeCount":62},[],{"trials":988,"activeCount":62},[],{"trials":990,"activeCount":62},[],{"trials":992,"activeCount":62},[],{"trials":994,"activeCount":62},[995],{"nctId":972,"briefTitle":973,"status":191,"phases":996,"primaryCompletion":975,"completion":976,"start":977,"enrollment":547,"conditions":997,"interventions":998},[55],[206],[957,980],{"intervention":1000,"totalTrials":58,"cells":1001},"Vaginal Diazepam Suppository",{"EARLY_PHASE1":1002,"PHASE1":1004,"PHASE2":1006,"PHASE3":1008,"PHASE4":1010,"NA":1012},{"trials":1003,"activeCount":62},[],{"trials":1005,"activeCount":62},[],{"trials":1007,"activeCount":62},[],{"trials":1009,"activeCount":62},[],{"trials":1011,"activeCount":62},[],{"trials":1013,"activeCount":62},[1014],{"nctId":1015,"briefTitle":1016,"status":191,"phases":1017,"primaryCompletion":1018,"completion":1018,"start":1019,"enrollment":1020,"conditions":1021,"interventions":1023},"NCT01233791","Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.",[55],"2011-12","2010-11",48,[1022],"Female Patients With High Tone Pelvic Floor Dysfunction",[1000],{"intervention":771,"totalTrials":58,"cells":1025},{"EARLY_PHASE1":1026,"PHASE1":1028,"PHASE2":1030,"PHASE3":1032,"PHASE4":1034,"NA":1036},{"trials":1027,"activeCount":62},[],{"trials":1029,"activeCount":62},[],{"trials":1031,"activeCount":62},[],{"trials":1033,"activeCount":62},[],{"trials":1035,"activeCount":62},[],{"trials":1037,"activeCount":62},[1038],{"nctId":762,"briefTitle":763,"status":191,"phases":1039,"primaryCompletion":765,"completion":765,"start":766,"enrollment":767,"conditions":1040,"interventions":1041},[55],[769],[499,771]]